Lipoprotein(a) and fibrinogen as predictors of complications in patients with acute coronary syndrome
Abstract
Introduction: Cardiovascular diseases are the cause of the largest number of annual deaths in the developped world, so they are considered a scourge on mankind; these include ischemic heart disease.Objectives: To determine the value of lipoprotein(a), fibrinogen and fibrinogen-lipoprotein(a) index in predicting short-term complications in patients with acute coronary syndrome.
Method: A cross-sectional descriptive study was conducted in 115 patients admitted with acute coronary syndrome to the Dr. Celestino Hernández Robau Hospital in Santa Clara, from November 2012 to October 2013.
Results: The study included 43 female and 72 male patients. The most frequent risk factors included hypertension (70.43%), dyslipidemia (50.43%) and a family history of coronary artery disease (47.83%). Complications occurred in 39 patients (33.9%). Cut-off points were established at 4.50 g/L for fibrinogen, 341 mg/L for lipoprotein(a) and 1.50 for fibrinogen-lipoprotein(a) index, which showed a sensitivity of 89%, specificity of 94% and a predictive ability given by an odds ratio of 122. Therefore it was classified as having a very good predictive value.
Conclusions: The fibrinogen-lipoprotein(a) index showed an excellent predictive value for short-term complications in patients with acute coronary syndrome.
Downloads
Download data is not yet available.
Downloads
Published
2015-10-11
How to Cite
1.
Carvajal Sánchez PA, Correa Morales AM, Reyes Hernández LM, Díaz Benítez RE, González Rivera EM, García Márquez M. Lipoprotein(a) and fibrinogen as predictors of complications in patients with acute coronary syndrome. CorSalud [Internet]. 2015 Oct. 11 [cited 2025 Sep. 21];7(4):275-84. Available from: https://revcorsalud.sld.cu/index.php/cors/article/view/75
Issue
Section
ORIGINAL ARTICLES
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.